脑机接口概念股继续走强，创新医疗8天5板

Group 1 - The A-share market saw a significant rise in brain-computer interface concept stocks, with notable increases including Botao Bio rising over 12%, Innovation Medical hitting the daily limit (5 consecutive days), Sanbo Brain Science increasing over 9%, Nanjing Panda up over 4%, Qisheng Technology up over 3%, and Aipeng Medical up over 2% [1] - Innovation Medical announced its investment in Bole Brain-Computer (Hangzhou) Technology Co., Ltd. (referred to as "Bole Brain-Computer") in early 2021, holding a 40% stake in the company [1] - Bole Brain-Computer focuses on the research and development of core brain-computer interface technologies and the design and production of related products, primarily applied in the medical rehabilitation field [1] - As of the announcement date, Bole Brain-Computer's products have not officially launched, with only a small number of products sold through collaborations with research institutions [1] - The operating losses for Bole Brain-Computer are projected to be 6.60 million yuan and 8.66 million yuan for 2023 and 2024, respectively [1]